23,338,039
Vote Records
27,979
Companies
11,817
Funds
4,051
Managers

Home › Companies › Disc Medicine, Inc. › 2025-2026

Disc Medicine, Inc. 2025-2026 Proxy Voting Records

Download data (CSV): ballot items · votes by manager · column guide.

Compiled from SEC Form N-PX filings and Disc Medicine, Inc.’s Form 8-K, filed June 24, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.

  • 5Ballot items
  • 221Asset managers, any item
  • 1,359Fund votes
  • June 18, 2026Meeting date

Results at a glance

Meeting of June 18, 2026: 5 items on Disc Medicine, Inc.’s Form 8-K, filed June 24, 2026: 2 approved · 3 passed (calculated).

Dissent

Notable dissent: 1 director (15.8% against).

Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Activist investors: Ra Capital Management, L.P. (13F, 5.4%, as of September 30, 2026)

Explore Disc Medicine, Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Disc Medicine, Inc.

These tallies are Disc Medicine, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 24, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Disc Medicine, Inc. — official shareholder meeting results, meeting held June 18, 2026
Ballot itemForAgainst AbstainWithheldBroker non-votesSupport (of votes cast)Reported outcomeVoting standard
Elect Director: Donald Nicholson, Ph.D. 28,559,799---- 5,347,4502,011,469 84%Passed (calculated)—
Elect Director: John Quisel, J.D., Ph.D. 33,433,078---- 474,1712,011,469 99%Passed (calculated)—
Elect Director: William White, M.P.P., J.D. 33,355,406---- 551,8432,011,469 98%Passed (calculated)—
2. Approval, on a Non-Binding, Advisory Basis, of the Compensation Paid to the Company's Named Executive Officers 33,528,449368,9709,830 --2,011,469 99%Approved—
3. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm 35,908,9001,2988,520 ---- 99.9%Approved—

Source: Disc Medicine, Inc., Form 8-K, filed with the SEC on June 24, 2026 — read the filing on EDGAR.

How asset managers voted at the Disc Medicine, Inc. 2025-2026 meeting

221 asset managers disclosed a vote on at least one Disc Medicine, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.

Elect Director: Donald Nicholson, Ph.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 5 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%WITHHELD
FOR: 28,559,799WITHHELD: 5,347,450
Details: description as filed, official tally, votes by 67 asset managers

Description as filed by funds: To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: Donald Nicholson, Ph.D.

Disc Medicine, Inc.’s own tally for this item (“Elect Director: Donald Nicholson, Ph.D.”): 28,559,799 for, 5,347,450 withheld, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 84% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 67 asset managers below reported 11,355,556 for, 1,647,909 withheld, 12 abstained.

FOR
FOR: 11,355,556ABSTAIN: 12WITHHOLD: 1,647,909
Largest asset managers voting on “To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nomi” at Disc Medicine, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity5,922,0610 00For
Vanguard1,608,8630 124,349For
T. Rowe Price976,6640 00For
JPMorgan824,9990 00For
State Street5880 0795,244Withhold
BlackRock460,8680 01,607For
MUTUAL FUND SERIES TRUST395,2350 03,972For
Charles Schwab252,6490 00For
Prudential/PGIM198,0210 01,202For
Hartford186,1660 00For
Loomis Sayles00 0172,923Withhold
Dimensional00 0165,288Withhold
Jackson National105,0340 05,727Mixed
Northwestern Mutual88,5480 00For
Aberdeen00 086,107Withhold
Victory Capital7410 083,651Withhold
Brighthouse40,0970 039,026Mixed
BNY Mellon58,8050 0986For
Equitable58,0500 00For
TIAA00 049,232Withhold
QUANTITATIVE MASTER SERIES LLC44,5030 00For
Columbia Threadneedle00 042,892Withhold
AIG/SunAmerica00 036,019Withhold
ALPS ETF Trust00 031,714Withhold
ProShares00 029,025Withhold

Showing the 25 largest of 67 asset managers. All 67 are in the interactive database (link above).

Elect Director: John Quisel, J.D., Ph.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

99% Majority: yes · of votes cast

FOR 99%
FOR: 33,433,078WITHHELD: 474,171
Details: description as filed, official tally, votes by 67 asset managers

Description as filed by funds: To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: John Quisel, J.D., Ph.D.

Disc Medicine, Inc.’s own tally for this item (“Elect Director: John Quisel, J.D., Ph.D.”): 33,433,078 for, 474,171 withheld, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 99% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 67 asset managers below reported 12,823,418 for, 180,058 withheld, 1 abstained.

FOR
FOR: 12,823,418ABSTAIN: 1WITHHOLD: 180,058
Largest asset managers voting on “To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nomi” at Disc Medicine, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity5,922,0610 00For
Vanguard1,610,3100 12,913For
T. Rowe Price976,6640 00For
JPMorgan824,9990 00For
State Street794,7830 01,049For
BlackRock462,4750 00For
MUTUAL FUND SERIES TRUST399,2070 00For
Charles Schwab252,6490 00For
Prudential/PGIM198,0210 01,202For
Hartford186,1660 00For
Loomis Sayles172,9230 00For
Dimensional00 0165,288Withhold
Jackson National105,0340 05,727Mixed
Northwestern Mutual88,5480 00For
Aberdeen86,1070 00For
Victory Capital84,3920 00For
Brighthouse79,1230 00For
BNY Mellon59,7910 00For
Equitable58,0500 00For
TIAA49,2320 00For
QUANTITATIVE MASTER SERIES LLC44,5030 00For
Columbia Threadneedle42,8920 00For
AIG/SunAmerica36,0190 00For
ALPS ETF Trust31,7140 00For
ProShares29,0250 00For

Showing the 25 largest of 67 asset managers. All 67 are in the interactive database (link above).

Elect Director: William White, M.P.P., J.D.

Calculated outcomeDIRECTOR ELECTIONSPassed (calculated)

Combines 6 wordings of this item as funds reported it.

98% Majority: yes · of votes cast

FOR 98%
FOR: 33,355,406WITHHELD: 551,843
Details: description as filed, official tally, votes by 67 asset managers

Description as filed by funds: To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nominees: William White, M.P.P., J.D.

Disc Medicine, Inc.’s own tally for this item (“Elect Director: William White, M.P.P., J.D.”): 33,355,406 for, 551,843 withheld, per its Form 8-K filed June 24, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Outcome: Passed (calculated) — The company’s filing reports the vote counts but does not state the outcome; we calculated it from the counts: votes for exceeded votes against.
Support: 98% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.

The 67 asset managers below reported 12,821,981 for, 181,494 withheld, 1 abstained.

FOR
FOR: 12,821,981ABSTAIN: 1WITHHOLD: 181,494
Largest asset managers voting on “To elect each of the following Class III nominees to the Board of Directors as set forth below: Class III Nomi” at Disc Medicine, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity5,922,0610 00For
Vanguard1,608,8740 14,349For
T. Rowe Price976,6640 00For
JPMorgan824,9990 00For
State Street794,7830 01,049For
BlackRock462,4750 00For
MUTUAL FUND SERIES TRUST399,2070 00For
Charles Schwab252,6490 00For
Prudential/PGIM198,0210 01,202For
Hartford186,1660 00For
Loomis Sayles172,9230 00For
Dimensional00 0165,288Withhold
Jackson National105,0340 05,727Mixed
Northwestern Mutual88,5480 00For
Aberdeen86,1070 00For
Victory Capital84,3920 00For
Brighthouse79,1230 00For
BNY Mellon59,7910 00For
Equitable58,0500 00For
TIAA49,2320 00For
QUANTITATIVE MASTER SERIES LLC44,5030 00For
Columbia Threadneedle42,8920 00For
AIG/SunAmerica36,0190 00For
ALPS ETF Trust31,7140 00For
ProShares29,0250 00For

Showing the 25 largest of 67 asset managers. All 67 are in the interactive database (link above).

Approval, on a Non-Binding, Advisory Basis, of the Compensation Paid to the Company's Named Executive Officers

Official resultFund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 9 wordings of this item as funds reported it.

99% Approved · of votes cast

FOR 99%
FOR: 33,528,449AGAINST: 368,970

Prior year: 99.2% for (June 11, 2025 meeting) ▼ 0.3 pts

Details: description as filed, official tally, votes by 221 asset managers

Description as filed by funds: TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.

Disc Medicine, Inc.’s own tally for this item (“2. Approval, on a Non-Binding, Advisory Basis, of the Compensation Paid to the Company's Named Executive Officers”): 33,528,449 for, 368,970 against — passed, per its Form 8-K filed June 24, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 2 - Approval, on a Non-Binding, Advisory Basis, of the Compensation Paid to the Company's Named Executive Officers The stockholders of the Company approved, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers as described in the Proxy Statement.”
Support: 99% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 65 asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at Disc Medicine, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity5,922,0610 00For
Vanguard1,613,2231 00For
T. Rowe Price976,6640 00For
JPMorgan824,9990 00For
State Street795,522310 00For
BlackRock462,4750 00For
MUTUAL FUND SERIES TRUST399,2070 00For
Charles Schwab252,6490 00For
Prudential/PGIM199,2230 00For
Hartford186,1660 00For
Loomis Sayles172,9230 00For
Dimensional165,2880 00For
Jackson National110,7610 00For
Northwestern Mutual88,5480 00For
Aberdeen86,1070 00For
Victory Capital84,3920 00For
Brighthouse79,1230 00For
BNY Mellon59,7910 00For
Equitable58,0500 00For
TIAA49,2320 00For
QUANTITATIVE MASTER SERIES LLC44,5030 00For
Columbia Threadneedle42,8920 00For
AIG/SunAmerica36,0190 00For
ALPS ETF Trust31,7140 00For
ProShares29,0250 00For

Fund voting reports, all 65 managers: 12,996,976 for, 5,529 against, 318 abstained. Showing the 25 largest; every one is in the interactive database (link above).

Institutional-manager reports: 176 asset managers voting on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED EXECUTIVE OFFICERS.” at Disc Medicine, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity5,409,3200 00For
RA CAPITAL MANAGEMENT, L.P.1,577,1060 00For
Atlas Venture Life Science Advisors, LLC1,513,8750 00For
T. Rowe Price1,393,8660 00For
Frazier Life Sciences Management, L.P.1,354,8520 00For
BVF INC/IL1,272,3120 00For
State Street1,134,0541,047 00For
ORBIMED ADVISORS LLC1,064,8640 00For
Siren, L.L.C.988,4010 00For
Wellington896,9840 00For
Woodline Partners LP767,3490 00For
GEODE CAPITAL MANAGEMENT, LLC623,4540 00For
BlackRock548,9352,317 810For
Vestal Point Capital, LP491,1100 00For
DEERFIELD MANAGEMENT COMPANY, L.P.479,7500 00For
Palo Alto Investors LP410,1210 00For
Aberdeen388,5340 00For
Foresite Capital Management V, LLC374,0690 00For
PICTET ASSET MANAGEMENT SA346,5130 00For
JENNISON ASSOCIATES LLC318,6040 00For
Loomis Sayles300,5880 00For
Octagon Capital Advisors LP267,3990 00For
Charles Schwab252,6960 00For
Vanguard250,8520 00For
Saturn V Capital Management LP245,4450 00For

Institutional-manager reports, all 176 managers: 24,539,323 for, 198,325 against, 158 abstained, 55 not voted. Showing the 25 largest; every one is in the interactive database (link above).

Ratification of Appointment of the Company's Independent Registered Public Accounting Firm

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.9% Approved · of votes cast

FOR 99.9%
FOR: 35,908,900AGAINST: 1,298

Prior year: 100.0% for (June 11, 2025 meeting) unchanged

Details: description as filed, official tally, votes by 67 asset managers

Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

Disc Medicine, Inc.’s own tally for this item (“3. Ratification of Appointment of the Company's Independent Registered Public Accounting Firm”): 35,908,900 for, 1,298 against — passed, per its Form 8-K filed June 24, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3 – Ratification of Appointment of the Company's Independent Registered Public Accounting Firm The stockholders of the Company ratified the appointment of Ernst & Young LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026.”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 67 asset managers below reported 13,003,159 for, 318 abstained.

FOR
FOR: 13,003,159ABSTAIN: 318
Largest asset managers voting on “TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM ” at Disc Medicine, Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Fidelity5,922,0610 00For
Vanguard1,613,2240 00For
T. Rowe Price976,6640 00For
JPMorgan824,9990 00For
State Street795,8320 00For
BlackRock462,4750 00For
MUTUAL FUND SERIES TRUST399,2070 00For
Charles Schwab252,6490 00For
Prudential/PGIM199,2230 00For
Hartford186,1660 00For
Loomis Sayles172,9230 00For
Dimensional165,2880 00For
Jackson National110,7610 00For
Northwestern Mutual88,5480 00For
Aberdeen86,1070 00For
Victory Capital84,3920 00For
Brighthouse79,1230 00For
BNY Mellon59,7910 00For
Equitable58,0500 00For
TIAA49,2320 00For
QUANTITATIVE MASTER SERIES LLC44,5030 00For
Columbia Threadneedle42,8920 00For
AIG/SunAmerica36,0190 00For
ALPS ETF Trust31,7140 00For
ProShares29,0250 00For

Showing the 25 largest of 67 asset managers. All 67 are in the interactive database (link above).

Largest Disc Medicine, Inc. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 38,190,464 shares outstanding at the time of that meeting.

Fund voting reports: top Disc Medicine, Inc. shareholders by shares voted on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED…”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 15.51%
2Vanguard 4.22%
3T. Rowe Price 2.56%
4JPMorgan 2.16%
5State Street 2.08%
6BlackRock 1.21%
7MUTUAL FUND SERIES TRUST 1.05%
8Charles Schwab 0.66%
9Prudential/PGIM 0.52%
10Hartford 0.49%
Institutional-manager reports: top Disc Medicine, Inc. shareholders by shares voted on “TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED…”, 2025-2026
#Asset manager % of shares outstanding
1Fidelity 14.16%
2RA CAPITAL MANAGEMENT, L.P. 4.13%
3Atlas Venture Life Science Advisors, LLC 3.96%
4T. Rowe Price 3.65%
5Frazier Life Sciences Management, L.P. 3.55%
6BVF INC/IL 3.33%
7State Street 2.97%
8ORBIMED ADVISORS LLC 2.79%
9Siren, L.L.C. 2.59%
10Wellington 2.35%

Reported Disc Medicine, Inc. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.

Disc Medicine, Inc. holdings and ownership disclosed for the 2025-2026 proxy season, with each row’s source and date
HolderShares % outstandingSource, as of
FMR (Fidelity)5,586,894 14.63%Form 13F, quarter ended March 31, 2026
FMR LLC5,300,016 13.88%Proxy statement (DEF 14A), proxy filed April 28, 2026
AI DMI LLC3,018,460 7.90%Proxy statement (DEF 14A), proxy filed April 28, 2026
BlackRock2,273,831 5.95%Form 13F, quarter ended March 31, 2026
RA Capital Management, L.P.2,228,924 5.84%Proxy statement (DEF 14A), proxy filed April 28, 2026
Vanguard Group1,767,680 4.63%Form 13F, quarter ended March 31, 2026
State Street1,698,244 4.45%Form 13F, quarter ended March 31, 2026
T. Rowe Price1,549,350 4.06%Form 13F, quarter ended March 31, 2026
JPMorgan Chase1,371,480 3.59%Form 13F, quarter ended March 31, 2026
Geode Capital744,222 1.95%Form 13F, quarter ended March 31, 2026

Percentages above are of 38,190,464 shares outstanding, as reported by Disc Medicine, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this meeting

At Disc Medicine, Inc.'s shareholder meeting held June 18, 2026, in the 2025-2026 proxy season, 221 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,359 separate fund positions. On the most widely held item on that ballot — TO APPROVE, ON A NON-BINDING, ADVISORY BASIS, THE COMPENSATION PAID TO THE COMPANY'S NAMED… — Disc Medicine, Inc.'s filing reports the proposal as approved, with 99% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Disc Medicine, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 24, 2026.

Related

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Disc Medicine, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.

Disc Medicine, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Cite this page

Proxy Votes Now, “Disc Medicine (IRON) 2026 Annual Meeting: Shareholder Vote Results”, https://proxyvotesnow.com/company/disc-medicine-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.